Agreed. The fact that potential oral use might be on the cards is significant.Oral efficacy was not part of what the trial was testing!
- Forums
- ASX - By Stock
- Ann: Antimicrobial Data Published in Peer-Reviewed Journal
Agreed. The fact that potential oral use might be on the cards...
-
-
- There are more pages in this discussion • 170 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add BOT (ASX) to my watchlist
|
|||||
Last
33.8¢ |
Change
0.003(0.75%) |
Mkt cap ! $535.5M |
Open | High | Low | Value | Volume |
36.0¢ | 36.5¢ | 33.8¢ | $6.587M | 18.70M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
46 | 1549930 | 33.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
34.0¢ | 480287 | 13 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
18 | 785393 | 0.340 |
43 | 1470473 | 0.335 |
35 | 582002 | 0.330 |
10 | 770792 | 0.325 |
16 | 1504314 | 0.320 |
Price($) | Vol. | No. |
---|---|---|
0.345 | 1001303 | 18 |
0.350 | 1160650 | 23 |
0.355 | 597190 | 9 |
0.360 | 578954 | 15 |
0.365 | 2047885 | 19 |
Last trade - 10.52am 21/06/2024 (20 minute delay) ? |
Featured News
BOT (ASX) Chart |
The Watchlist
HAR
HARANGA RESOURCES LIMITED.
Peter Batten, MD
Peter Batten
MD
Previous Video
Next Video
SPONSORED BY The Market Online